Medial Temporal Atrophy Alone is Insufficient to Predict Underlying Alzheimer’s Disease Pathology
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The medial temporal region is the earliest affected structure in patients with Alzheimer’s disease (AD), and its atrophy is known as the hallmark of AD. This study aimed to investigate the value of medial temporal atrophy (MTA) for detecting 18F-florbetaben positron emission tomography (PET)-proven AD pathology. Methods: We retrospectively enrolled 265 subjects complaining of cognitive decline at a dementia outpatient clinic from March 2015 to December 2017. All subjects underwent brain magnetic resonance imaging, 18F-fluorodeoxyglucose PET, and 18F-florbetaben PET at baseline. We performed multivariable logistic regression analyses on variables including age, sex, years of education, white matter hyperintensities, apolipoprotein E (APOE) genotype, and memory composite scores in various combinations to investigate whether MTA was indicative of underlying AD pathology. Results: Our sample population of 265 patients comprised 121 with AD-related cognitive impairment, 42 with Lewy bodies-related cognitive impairment, 32 with vascular cognitive impairment, and 70 with other or undetermined pathologies. In the multivariable logistic regression analyses, MTA was not an independent predictor of underlying AD pathology (P>0.200). The predictive power of underlying AD-related cognitive impairment significantly increased when multiple variables including APOE genotype and memory composite scores were considered together (area under the curve >0.750). Conclusion: Our results suggest that MTA alone may be insufficient to accurately predict the presence of AD pathology. It is necessary to comprehensively consider various other factors such as APOE genotype and a detailed memory function to determine whether the patient is at high risk of AD.
Abstract
Background: The medial temporal region is the earliest affected structure in patients with Alzheimer’s disease (AD), and its atrophy is known as the hallmark of AD. This study aimed to investigate the value of medial temporal atrophy (MTA) for detecting 18F-florbetaben positron emission tomography (PET)-proven AD pathology. Methods: We retrospectively enrolled 265 subjects complaining of cognitive decline at a dementia outpatient clinic from March 2015 to December 2017. All subjects underwent brain magnetic resonance imaging, 18F-fluorodeoxyglucose PET, and 18F-florbetaben PET at baseline. We performed multivariable logistic regression analyses on variables including age, sex, years of education, white matter hyperintensities, apolipoprotein E (APOE) genotype, and memory composite scores in various combinations to investigate whether MTA was indicative of underlying AD pathology. Results: Our sample population of 265 patients comprised 121 with AD-related cognitive impairment, 42 with Lewy bodies-related cognitive impairment, 32 with vascular cognitive impairment, and 70 with other or undetermined pathologies. In the multivariable logistic regression analyses, MTA was not an independent predictor of underlying AD pathology (P>0.200). The predictive power of underlying AD-related cognitive impairment significantly increased when multiple variables including APOE genotype and memory composite scores were considered together (area under the curve >0.750). Conclusion: Our results suggest that MTA alone may be insufficient to accurately predict the presence of AD pathology. It is necessary to comprehensively consider various other factors such as APOE genotype and a detailed memory function to determine whether the patient is at high risk of AD.
참고문헌 (30)
- Abdulrab K, "Subjective memory impairment : a review of its definitions indicates the need for a comprehensive set of standardised and validated criteria", Eur Psychiatry, 23, pp.321~330 (2008)
- Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
- Devanand DP, "Hippocampal and entorhinal atrophy in mild cognitive impairment : prediction of Alzheimer disease", Neurology, 68, pp.828~836 (2007)
- Launer LJ, "Medial temporal lobe atrophy in an open population of very old persons : cognitive, brain atrophy, and sociomedical correlates", Neurology, 45, pp.747~752 (1995)
- Tam CW, "Temporal lobe atrophy on MRI in Parkinson disease with dementia : a comparison with Alzheimer disease and dementia with Lewy bodies", Neurology, 64, pp.861~865 (2005)
- Visser PJ, "Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment", J Neurol Neurosurg Psychiatry, 72, pp.491~497 (2002)
- Bouwman FH, "CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment", Neurobiol Aging, 28, pp.1070~1074 (2007)
- Burton EJ, "Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment : a prospective study with pathological verification of diagnosis", Brain, 132(Pt 1), pp.195~203 (2009)
- Prestia A, "Diagnostic accuracy of markers for prodromal Alzheimer’s disease in independent clinical series", Alzheimers Dement, 9, pp.677~686 (2013)
- Harper L, "MRI visual rating scales in the diagnosis of dementia : evaluation in 184 post-mortem confirmed cases", Brain, 139(Pt 4), pp.1211~1225 (2016)
- 안현정, "Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients", Journal of Korean Medical Science, 25(7), pp.1071~1076 (2010), 대한의학회
- Scheltens P, "Atrophy of medial temporal lobes on MRI in"probable"Alzheimer’s disease and normal ageing : diagnostic value and neuropsychological correlates", J Neurol Neurosurg Psychiatry, 55, pp.967~972 (1992)
- Schoonenboom NS, "CSF and MRI markers independently contribute to the diagnosis of Alzheimer’s disease", Neurobiol Aging, 29, pp.669~675 (2008)
- Pereira JB, "Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs", J Intern Med, 275, pp.317~330 (2014)
- Claus JJ, "Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease : validation in a large memory clinic population", Eur Radiol, 27, pp.3147~3155 (2017)
- Fazekas F, "MR signal abnormalities at 1. 5 T in Alzheimer’s dementia and normal aging", AJR Am J Roentgenol, 149, pp.351~356 (1987)
- Noh Y, "A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities", J Stroke Cerebrovasc Dis, 23, pp.636~642 (2014)
- Sabri O, "Beta-amyloid imaging with florbetaben", Clin Transl Imaging, 3, pp.13~26 (2015)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- Landau SM, "Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI", Neurobiol Aging, 32, pp.1207~1218 (2011)
- Schipke CG, "Correlation of florbetaben PET imaging and the amyloid peptide Aß42in cerebrospinal fluid", Psychiatry Res Neuroimaging, 265, pp.98~101 (2017)
- Morris E, "Diagnostic accuracy of(18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease : a systematic review and meta-analysis", Eur J Nucl Med Mol Imaging, 43, pp.374~385 (2016)
- Ong KT, "Aβ imaging with 18F-florbetaben in prodromal Alzheimer’s disease : a prospective outcome study", J Neurol Neurosurg Psychiatry, 86, pp.431~436 (2015)
- Schneider JA, "Mixed brain pathologies account for most dementia cases in community-dwelling older persons", Neurology, 69, pp.2197~2204 (2007)
- Galton CJ, "Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia", Neurology, 57, pp.216~225 (2001)
- Jack CR Jr, "Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade", Lancet Neurol, 9, pp.119~128 (2010)
- Braak H, "Staging of Alzheimer’s disease-related neurofibrillary changes", Neurobiol Aging, 16, pp.271~284 (1995)
- Yu JT, "Apolipoprotein E in Alzheimer’s disease : an update", Annu Rev Neurosci, 37, pp.79~100 (2014)
- Weintraub S, "The neuropsychological profile of Alzheimer disease", Cold Spring Harb Perspect Med, 2, pp.a006171~ (2012)
- Wattjes MP, "Diagnostic imaging of patients in a memory clinic : comparison of MR imaging and 64-detector row CT", Radiology, 253, pp.174~183 (2009)